War, unfortunately, is often bullish for stocks, writes Joe Duarte.
In 2019, Dr. Joe Duarte, editor of In the Money Options, selected Texas Instruments (TXN) as his Top Pick; the stock has risen 37%. He now turns to a pharmaceutical favorite as a top pick for 2020.
The Pharmaceutical sector appears ready for multiple breakthroughs, writes Joe Duarte.
While fear of the end of this long bull move is rising, there are many reason for optimism going forward, writes Joe Duarte.
Two reliable housing stocks, DR Horton (DHI) and KB Home (KBH) seem to be righting their respective ships, observes Dr. Joe Duarte, growth stock expert and editor of In the Money Options.
Keep an eye on these Big Pharma names, likely to outperform, says Joe Duarte.
No trade deal is imminent, but traders need to be prepared for unlikely scenarios at yearend, reports Joe Duarte.
Homebuilders may be the sector to watch, writes Joe Duarte.
Kohl’s poor number last week highlights the potential chaos markets are facing, notes Joe Duarte.
Will reports of a trade deal spike stocks on slow trading week, asks Joe Duarte.
Kohl’s is looking strong on the eve of today’s earnings announcement, reports Joe Duarte.
The trend is your friend, but trends can reverse so traders need to remain vigilant warns Joe Duarte.
Pharmaceutical stocks have been beyond wallflowers in 2019. In fact, some of them, like drug giant Pfizer (PFE) have been right down in the fallen angel category until recently, observes growth stock expert Joe Duarte, editor of In the Money Options.
Equity Bulls are in Control, but Stocks are in a Bullish Mood and are caught between the Fed’s Liquidity Push and that Pesky Bond Market.
A new drug could send shares of Pfizer (PFE) much higher, writes Joe Duarte.
All signs show continued upward momentum in Stocks, don’t fight it, but know how it will end, writes Joe Duarte.
Despite the late summer warning signs, stocks appear strong and we’re heading to a seasonal strong point, notes Joe Duarte.
Shares of homebuilder KB Home (KBH) have rallied over thirty percent since their August 2019 breakout; despite these gains the shares may still have some upside left, suggests Joe Duarte, growth stock expert and editor of In the Money Options.
The economy appears strong despite multiple headlines of doom, writes Joe Duarte, who says the only thing to fear is a potential liquidity crisis at the FED.
What the Fed and the bond market do is almost more important than any trade deal, writes Joe Duarte.